Expertise
With a team of specialists with over 20 years expertise, ID SOLUTIONS develops, produces and markets in-vitro diagnostic kits in the fields of oncology and infectiology. ID SOLUTIONS also develops a wide range of reagents and instruments dedicated to research.
Our mission is to facilitate patient access to faster, affordable, precision medical diagnostics. We strive to offer products at the cutting edge of innovation
Lise GREWIS, CEO d'ID SOLUTIONS
Innovation in oncology diagnostics
ID SOLUTIONS develops, manufactures and markets a complete solution for oncology diagnostics, based on purified circulating DNA or DNA extracted from frozen or paraffin-embedded tissue (FFPE).
The company offers standard operating procedures and highly sensitive diagnostic tools to meet today’s clinical oncology requirements.
A complete solution for infectious diseases
Our team has developed a wide range of qPCR detection kits for infectious diseases, tropical diseases and sexually transmitted diseases..
The company has also developed a complete solution for the molecular diagnosis of SARS-CoV-2, enabling very high throughput ranging from 2,000 to 13,000 analyses/day.
It includes automated systems, consumables and extraction reagents, as well as a range of highly sensitive RT-qPCR amplification kits.
Our range of tests is regularly updated in line with developments in the screening strategy for mutations of interest, and is closely monitored by our team.
